Table 5 of Mayinu, Mol Vis 2011; 17:1734-1744.
Genotype count (proportion) | Allele count (proportion) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Gender | Group | rs1048661 (n) | TT | GT | GG | χ2 | p value | G | T | χ2 | p value | OR (95%CI) |
Male | XFS/XFG | 41 | 1 (0.02) | 14 (0.34) | 26 (0.63) | 4.08 | 0.130 | 66 (0.80) | 16 (0.20) | 3.92 | 0.048 | 1.90 (1.00–3.59) |
Control | 81 | 10 (0.12) | 31 (0.38) | 40 (0.49) | 111 (0.69) | 51 (0.31) | ||||||
Female | XFS/XFG | 23 | 1 (0.04) | 6 (0.26) | 16 (0.70) | 4.98 | 0.083 | 38 (0.83) | 8 (0.17) | 2.32 | 0.128 | 1.97 (0.82–4.78) |
Control | 46 | 1 (0.02) | 25 (0.54) | 20 (0.43) | 65 (0.71) | 27 (0.29) | ||||||
Genotype count (proportion) | Allele count (proportion) | |||||||||||
Gender | Group | rs2165241 (n) | CC | CT | TT | χ2 | p value | T | C | χ2 | p value | OR (95%CI) |
Male | XFS/XFG | 41 | 12 (0.29) | 19 (0.46) | 10 (0.24) | 9.45 | 0.009 | 39 (0.48) | 43 (0.52) | 10.8 | 0.001 | 2.51 (1.44–4.39) |
Control | 81 | 46 (0.57) | 27 (0.33) | 8 (0.10) | 43 (0.27) | 119 (0.73) | ||||||
Female | XFS/XFG | 23 | 2 (0.09) | 9 (0.39) | 12 (0.52) | 27.6 | 0.000 | 33 (0.72) | 13 (0.28) | 34.1 | 0.000 | 9.75 (4.31–22.07) |
Control | 46 | 29 (0.63) | 15 (0.33) | 2 (0.04) | 19 (0.21) | 73 (0.79) | ||||||
Genotype count (proportion) | Allele count (proportion) | |||||||||||
Gender | Group | rs3825942 (n) | GG | GA | AA | χ2 | p value | G | A | χ2 | p value | OR (95%CI) |
Male | XFS/XFG | 41 | 36 (0.88) | 5 (0.12) | 0 (0.00) | 8.41 | 0.015 | 77 (0.94) | 5 (0.06) | 7.89 | 0.005 | 3.79 (1.42–10.14) |
Control | 81 | 51 (0.63) | 28 (0.35) | 2 (0.02) | 130 (0.80) | 32 (0.20) | ||||||
Female | XFS/XFG | 23 | 22 (0.96) | 1 (0.04) | 0 (0.00) | 8.46 | 0.004 | 45 (0.98) | 1 (0.02) | 7.19 | 0.007 | 10.2 (1.31–79.26) |
Control | 46 | 29 (0.63) | 17 (0.37) | 0 (0.00) | 75 (0.82) | 17 (0.18) |